ReviewHandbook of experimental pharmacology2026
Hydrogen Sulfide in Adipose Tissue Biology.
Review in Handbook of experimental pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past several decades, sulfide has emerged as an important signaling molecule, playing diverse physiological and pathological roles across a broad spectrum of human health conditions. Among its recently recognized systemic effects, sulfide has been identified as a key regulator of adipose tissue (AT) homeostasis; its critical involvement in numerous adipose tissue functions, including adipogenesis, lipogenesis, and lipid and glucose metabolism, has been reported. Growing evidence indicates that dysregulation of H₂S signaling within the adipose tissue contributes to the development and progression of obesity and related metabolic disorders. The pharmacological modulation of endogenous sulfide levels is being actively explored as a promising therapeutic strategy for improving metabolic health. Herein, we provide a comprehensive and critical review of the current literature on the role of sulfide in adipose tissue biology and physiology. Particular emphasis is placed on the broader implications of sulfide signaling in the prevention and treatment of obesity.
Indexed as
Identifiers
41461957What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.